CT assessment of the effect of fluticasone propionate aqueous nasal spray treatment on lower turbinate hypertrophy due to vasomotor rhinitis

Basit Öğe Kaydı
dc.contributor.authorArıkan, Osman Kürşat
dc.contributor.authorKoç, Can
dc.contributor.authorKendi, Tuğba
dc.contributor.authorMuluk, Nuray Bayar
dc.contributor.authorEkici, Aydanur
dc.date.accessioned2020-06-25T17:41:08Z
dc.date.available2020-06-25T17:41:08Z
dc.date.issued2006
dc.departmentKırıkkale Üniversitesi
dc.description.abstractConclusion. Fluticasone propionate ( FP) aqueous nasal spray was objectively found to be effective and safe for the treatment of lower turbinate enlargement in patients with vasomotor rhinitis. Objective. To assess the efficacy of FP aqueous nasal spray treatment in lower turbinate hypertrophy due to vasomotor rhinitis using CT. Material and methods. Of 35 patients with hypertrophic lower turbinates due to vasomotor rhinitis, 20 were treated twice daily with FP aqueous nasal spray ( 200 mu g/day) for 3 months continuously and 15 were treated with placebo vehicle as a control group. The local effect of the nasal spray was studied using CT and visual analog scales. Results. Treatment with FP provided significantly greater relief from the symptom of nasal obstruction compared with placebo over the entire 3-month treatment period ( p< 0.001). When the change from baseline was compared between the two groups, FP produced statistically significant reductions in the mucosal area of the lower turbinates and in the thickness of the nasal mucosa after 3 months (p< 0.05).en_US
dc.identifier.citationclosedAccessen_US
dc.identifier.doi10.1080/00016480510012219
dc.identifier.endpage42en_US
dc.identifier.issn0001-6489
dc.identifier.issn1651-2251
dc.identifier.issue1en_US
dc.identifier.pmid16308253
dc.identifier.scopus2-s2.0-28844493687
dc.identifier.scopusqualityQ2
dc.identifier.startpage37en_US
dc.identifier.urihttps://doi.org/10.1080/00016480510012219
dc.identifier.urihttps://hdl.handle.net/20.500.12587/3636
dc.identifier.volume126en_US
dc.identifier.wosWOS:000233618400007
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltden_US
dc.relation.ispartofActa Oto-Laryngologica
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCTen_US
dc.subjectfluticasone propionateen_US
dc.subjectlower turbinate hypertrophyen_US
dc.subjectvasomotor rhinitisen_US
dc.titleCT assessment of the effect of fluticasone propionate aqueous nasal spray treatment on lower turbinate hypertrophy due to vasomotor rhinitisen_US
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
CT assessment of the effect of fluticasone propionate aqueous nasal spray treatment on lower turbinate hypertrophy due to vasomotor rhinitis.pdf
Boyut:
375.51 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/Full Text
İndir

Koleksiyon

WOS İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu